Centivax, Inc.
PrivateLast Round
VC Round
Mar 30, 2026
Total Funding Raised
$79.99M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Centivax, Inc. is a biotechnology company that deploys a proprietary computational immune-engineering platform to create universal vaccines and therapies for infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Centivax, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Centivax, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 30, 2026 | ||||
| Grant | Jul 8, 2025 | ||||
| Series A | Jul 8, 2025 | ||||
| Seed | Nov 16, 2022 | ||||
| Grant | Nov 1, 2019 |
Key People
Founding team and executive leadership
Centivax, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kendall Capital Partners | Series A, VC Round |
| NFX | Series A, Seed |
| Future Ventures | Series A |
| CEPI | Grant |
| NIH RADx | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Base4 Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
$37M raised in early funding round.
- Mar 30, 2026
Developing a next-generation universal vaccine platform with support from Meiji Seika Pharma.
Centivax, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Centivax, Inc.'s valuation, stock price, and market status.